Experimental Therapies for Ebola Virus Disease: What Have We Learned?

被引：22

|

作者：

Hayden, Frederick G. ^{[1
]}

Friede, Martin ^{[2
]}

Bausch, Daniel G. ^{[2
]}

机构：

[1] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA

[2] World Hlth Org, Geneva, Switzerland

来源：

JOURNAL OF INFECTIOUS DISEASES | 2017年 / 215卷 / 02期

基金：

英国惠康基金;

关键词：

Ebola; antivirals; immunotherapeutics; clinical research; HEMORRHAGIC-FEVER; NONHUMAN-PRIMATES; PERSISTENCE; PATIENT; FLUID;

D O I：

10.1093/infdis/jiw496

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

收藏

页码：167 / 170

页数：4

相关论文

共 50 条

[1] Experimental Therapies for Ebola Virus Disease: What Have We Learned? (vol 215, pg 167, 2017)
Hayden
JOURNAL OF INFECTIOUS DISEASES, 2017, 215 (10): : 1629 - 1629
[2] Ebola, epidemics, and ethics - what we have learned
G Kevin Donovan
Philosophy, Ethics, and Humanities in Medicine, 9
[3] Ebola, epidemics, and ethics - what we have learned
Donovan, G. Kevin
PHILOSOPHY ETHICS AND HUMANITIES IN MEDICINE, 2014, 9
[4] New therapies in Alzheimer's disease - What have we learned?
Dodel, R.
IMMUNOLOGY, 2011, 135 : 24 - 24
[5] Zika Virus: What Have We Learned?
Palazzi Safadi, Marco Aurelio
AMERICAN JOURNAL OF PERINATOLOGY, 2016, 33 (11) : 1029 - 1031
[6] Ocular manifestations of Ebola virus disease: What we learned from the last epidemic
Rousseau, A.
Labetoulle, M.
JOURNAL FRANCAIS D OPHTALMOLOGIE, 2015, 38 (08): : 758 - 763
[7] EXPERIMENTAL ENDOCARDITIS - WHAT HAVE WE LEARNED
PETERSDORF, RG
CIRCULATION, 1976, 54 (04) : 2 - 2
[8] Ebola-what have we learned from the recent outbreak?
Heron, Richard J. L.
OCCUPATIONAL MEDICINE-OXFORD, 2016, 66 (01): : 4 - 7
[9] What have we learned in dermatology from the biologic therapies?
Nickoloff, BJ
Stevens, SR
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : S143 - S151
[10] The challenges of treating Ebola virus disease with experimental therapies
Aoyama, Kazuyoshi
Fowler, Robert A.
LANCET RESPIRATORY MEDICINE, 2015, 3 (07): : 503 - 504

← 1 2 3 4 5 →